• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在汤姆·贝克癌症中心接受治疗的子宫肉瘤患者的特征与管理

Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre.

作者信息

Kelly K-L J, Craighead P S

机构信息

Department of Radiation Oncology, Tom Baker Cancer Centre, 1331-29 Street NW, Calgary, Alberta T2N 4N2, Canada.

出版信息

Int J Gynecol Cancer. 2005 Jan-Feb;15(1):132-9. doi: 10.1111/j.1048-891x.2005.15014.x.

DOI:10.1111/j.1048-891x.2005.15014.x
PMID:15670308
Abstract

The purpose of this study was to evaluate patients with uterine sarcoma from Southern Alberta to assess patterns of care and outcomes associated with treatment by a multidisciplinary team. Using the Alberta Cancer Registry database, charts of all uterine sarcoma patients treated between 1988 and 1997 in Southern Alberta were extracted. The majority of patients underwent definitive surgery. Adjuvant treatments were performed in selected patients at the discretion of the multidisciplinary tumor board. Demographics, management, and outcomes were collected into an electronic database. Eighty-seven patients were treated for uterine sarcoma at the Tom Baker Cancer Centre from 1988 to 1997. The 5-year overall survival rate was 48% and the 10-year overall survival rate was 21%. Univariate analysis demonstrated that stage, histologic subtype, and treatment with radiation therapy had a significant effect on local control and that stage and histologic subtype had a significant effect on survival. Stage was significant in the multivariate analysis for both local control (P = 0.008) and overall survival (P = 0.0001). Based on the findings in this series, stage remains a significant prognostic factor for patients with uterine sarcoma. Multidisciplinary care in the local setting reduced the use of adjuvant therapy without impacting adversely on survival or local control.

摘要

本研究的目的是评估来自阿尔伯塔省南部的子宫肉瘤患者,以评估多学科团队治疗的护理模式及相关预后。利用阿尔伯塔癌症登记数据库,提取了1988年至1997年间在阿尔伯塔省南部接受治疗的所有子宫肉瘤患者的病历。大多数患者接受了根治性手术。多学科肿瘤委员会酌情为部分患者进行了辅助治疗。将人口统计学、治疗管理及预后情况录入电子数据库。1988年至1997年期间,有87例子宫肉瘤患者在汤姆·贝克癌症中心接受治疗。5年总生存率为48%,10年总生存率为21%。单因素分析表明,分期、组织学亚型及放疗对局部控制有显著影响,分期和组织学亚型对生存率有显著影响。在多因素分析中,分期对局部控制(P = 0.008)和总生存率(P = 0.0001)均有显著意义。基于本系列研究结果,分期仍是子宫肉瘤患者的重要预后因素。在当地进行多学科护理减少了辅助治疗的使用,且未对生存率或局部控制产生不利影响。

相似文献

1
Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre.在汤姆·贝克癌症中心接受治疗的子宫肉瘤患者的特征与管理
Int J Gynecol Cancer. 2005 Jan-Feb;15(1):132-9. doi: 10.1111/j.1048-891x.2005.15014.x.
2
Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.子宫肉瘤:伊朗的临床病理特征、治疗及预后
Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):421-6.
3
Update on treatment of uterine sarcoma.子宫肉瘤治疗进展。
Curr Opin Obstet Gynecol. 2010 Feb;22(1):36-42. doi: 10.1097/GCO.0b013e328334d90f.
4
Uterine sarcoma-current management and experience from a regional cancer centre in North India.子宫肉瘤——印度北部一个地区癌症中心的当前管理和经验。
Arch Gynecol Obstet. 2013 Oct;288(4):873-82. doi: 10.1007/s00404-013-2843-7. Epub 2013 Apr 12.
5
High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.高级别未分化子宫肉瘤:手术、治疗和生存结果。
Gynecol Oncol. 2012 Oct;127(1):27-31. doi: 10.1016/j.ygyno.2012.06.030. Epub 2012 Jun 26.
6
Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.1984年至1994年间,汤姆·贝克癌症中心对侵袭性子宫内膜癌组织学变异型的管理。
Gynecol Oncol. 2000 May;77(2):248-53. doi: 10.1006/gyno.2000.5746.
7
[Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].[子宫肉瘤:临床与组织病理学特征。15例报告]
Gynecol Obstet Fertil. 2008 Jun;36(6):628-35. doi: 10.1016/j.gyobfe.2008.03.012. Epub 2008 Jun 5.
8
Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.100例子宫肉瘤的临床结局及预后因素:赫尔辛基大学中心医院1990 - 2001年的经验
Gynecol Oncol. 2008 Oct;111(1):74-81. doi: 10.1016/j.ygyno.2008.06.002. Epub 2008 Jul 26.
9
Uterine sarcoma: 14 years experience in KCCC.子宫肉瘤:科威特癌症控制中心14年经验
Gulf J Oncolog. 2008 Jul(4):45-51.
10
[Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].[子宫肉瘤的手术及术后放射治疗。复发模式、预后因素及放射治疗的作用]
Bull Cancer. 1997 Jun;84(6):625-9.

引用本文的文献

1
Uterine Sarcomas: A Retrospective Analysis of a Cohort of 62 Patients.子宫肉瘤:62例患者队列的回顾性分析
Cureus. 2021 Feb 15;13(2):e13349. doi: 10.7759/cureus.13349.
2
Uterine sarcoma. Clinico-pathological characteristics and outcome.子宫肉瘤。临床病理特征与预后
Saudi Med J. 2014 Oct;35(10):1215-22.
3
[Uterine sarcoma treatment].[子宫肉瘤治疗]
Pathologe. 2009 Jul;30(4):304-12. doi: 10.1007/s00292-009-1150-3.
4
Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.子宫肉瘤患者的预后因素及治疗结果:对1989年至2007年一家机构127例患者的分析
J Cancer Res Clin Oncol. 2008 Dec;134(12):1277-87. doi: 10.1007/s00432-008-0422-2. Epub 2008 May 28.